We provide you with 20 years of free, institutional-grade data for NUVL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NUVL. Explore the full financial landscape of NUVL stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$21,490,136
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Porter James Richard | Sale | -30,000 | $123.72 | $3,711,600 | 2026-07-08 |
| Porter James Richard | Derivatives Exercise | 30,000 | 2026-07-08 | ||
| Noci Darlene | Sale | -23,000 | $123.59 | $2,842,570 | 2026-07-06 |
| Noci Darlene | Derivatives Exercise | 23,000 | 2026-07-06 | ||
| Balcom Alexandra | Sale | -11,430 | $123.58 | $1,412,519 | 2026-07-06 |
| Balcom Alexandra | Derivatives Exercise | 11,430 | 2026-07-06 | ||
| Noci Darlene | Sale | -5,500 | $123.51 | $679,305 | 2026-07-01 |
| Noci Darlene | Derivatives Exercise | 5,500 | 2026-07-01 | ||
| Wheeler Cameron | Grant, award...etc | 3,444 | 2026-06-18 | ||
| Srivastava Sapna | Grant, award...etc | 3,444 | 2026-06-18 | ||
| Squarer Ron | Grant, award...etc | 3,444 | 2026-06-18 | ||
| Protopapas Anna | Grant, award...etc | 3,444 | 2026-06-18 | ||
| Oliger Christy J. | Grant, award...etc | 3,444 | 2026-06-18 | ||
| Meyers Michael L. | Grant, award...etc | 3,444 | 2026-06-18 | ||
| Bogle Grant C. | Grant, award...etc | 3,444 | 2026-06-18 | ||
| Flynn James E | Grant, award...etc | 3,444 | 2026-06-18 | ||
| Noci Darlene | Sale | -20,000 | $122.81 | $2,456,200 | 2026-06-11 |
| Noci Darlene | Derivatives Exercise | 20,000 | 2026-06-11 | ||
| Porter James Richard | Sale | -30,000 | $87.97 | $2,639,100 | 2026-06-10 |
| Porter James Richard | Derivatives Exercise | 30,000 | 2026-06-10 | ||
| Balcom Alexandra | Sale | -11,430 | $94.87 | $1,084,364 | 2026-06-03 |
| Balcom Alexandra | Derivatives Exercise | 11,430 | 2026-06-03 | ||
| Noci Darlene | Sale | -5,500 | $106.26 | $584,430 | 2026-06-01 |
| Noci Darlene | Derivatives Exercise | 5,500 | 2026-06-01 | ||
| Miller Deborah Ann | Sale | -5,500 | $106.32 | $584,760 | 2026-06-01 |
| Miller Deborah Ann | Derivatives Exercise | 5,500 | 2026-06-01 | ||
| Porter James Richard | Sale | -30,000 | $98.54 | $2,956,200 | 2026-05-06 |
| Porter James Richard | Derivatives Exercise | 30,000 | 2026-05-06 | ||
| Balcom Alexandra | Sale | -11,430 | $98.42 | $1,124,941 | 2026-05-05 |
| Balcom Alexandra | Derivatives Exercise | 11,430 | 2026-05-05 | ||
| Noci Darlene | Sale | -5,500 | $99.35 | $546,425 | 2026-05-01 |
| Noci Darlene | Derivatives Exercise | 5,500 | 2026-05-01 | ||
| Miller Deborah Ann | Sale | -5,500 | $99.13 | $545,215 | 2026-05-01 |
| Miller Deborah Ann | Derivatives Exercise | 5,500 | 2026-05-01 | ||
| Pelish Henry E. | Sale | -3,093 | $104.27 | $322,507 | 2026-04-13 |
| Pelish Henry E. | Derivatives Exercise | 3,093 | 2026-04-13 | ||
| Porter James Richard | Sale | -30,000 | $103.21 | $3,096,300 | 2026-04-08 |
| Porter James Richard | Derivatives Exercise | 30,000 | 2026-04-08 | ||
| Balcom Alexandra | Sale | -11,430 | $104.39 | $1,193,178 | 2026-04-03 |
| Balcom Alexandra | Derivatives Exercise | 11,430 | 2026-04-03 | ||
| Lane Benjamin | Grant, award...etc | 9,500 | 2026-04-02 | ||
| Noci Darlene | Sale | -5,500 | $97.43 | $535,865 | 2026-04-01 |
| Noci Darlene | Derivatives Exercise | 5,500 | 2026-04-01 | ||
| Miller Deborah Ann | Sale | -5,500 | $97.5 | $536,250 | 2026-03-30 |
| Miller Deborah Ann | Derivatives Exercise | 5,500 | 2026-03-30 | ||
| Balcom Alexandra | Sale | -25,130 | $95.03 | $2,388,104 | 2026-03-26 |
| Balcom Alexandra | Derivatives Exercise | 11,430 | 2026-03-26 | ||
| Lane Benjamin | Initial | 2026-03-20 | |||
| Pelish Henry E. | Sale | -35,104 | $97.79 | $3,432,820 | 2026-03-16 |
| Pelish Henry E. | Derivatives Exercise | 17,320 | 2026-03-16 | ||
| Porter James Richard | Sale | -30,000 | $98.59 | $2,957,700 | 2026-03-10 |
| Porter James Richard | Derivatives Exercise | 30,000 | 2026-03-10 | ||
| Noci Darlene | Sale | -5,500 | $102.64 | $564,520 | 2026-03-02 |
| Noci Darlene | Derivatives Exercise | 5,500 | 2026-03-02 | ||
| Miller Deborah Ann | Sale | -5,500 | $102.64 | $564,520 | 2026-03-02 |
| Miller Deborah Ann | Derivatives Exercise | 5,500 | 2026-03-02 | ||
| Noci Darlene | Sale | -5,500 | $100.95 | $555,225 | 2026-02-02 |
| Noci Darlene | Derivatives Exercise | 5,500 | 2026-02-02 | ||
| Noci Darlene | Grant, award...etc | 17,500 | 2026-01-07 | ||
| Noci Darlene | Sale | -7,417 | $96.06 | $712,477 | 2026-01-07 |
| Miller Deborah Ann | Grant, award...etc | 17,500 | 2026-01-07 | ||
| Miller Deborah Ann | Sale | -6,952 | $96.06 | $667,809 | 2026-01-07 |
| Turner Christopher Durant | Grant, award...etc | 17,500 | 2026-01-07 | ||
| Turner Christopher Durant | Sale | -7,417 | $96.06 | $712,477 | 2026-01-07 |
| Balcom Alexandra | Grant, award...etc | 17,500 | 2026-01-07 | ||
| Balcom Alexandra | Sale | -7,417 | $96.06 | $712,477 | 2026-01-07 |
| Porter James Richard | Grant, award...etc | 46,250 | 2026-01-07 | ||
| Porter James Richard | Sale | -27,433 | $96.06 | $2,635,214 | 2026-01-07 |
| Pelish Henry E. | Grant, award...etc | 17,500 | 2026-01-07 | ||
| Pelish Henry E. | Sale | -5,160 | $96.06 | $495,670 | 2026-01-07 |
| Miller Deborah Ann | Sale | -10,000 | $100.03 | $1,000,300 | 2026-01-05 |
| Miller Deborah Ann | Derivatives Exercise | 10,000 | 2026-01-05 | ||
| Noci Darlene | Sale | -4,000 | $99.82 | $399,280 | 2026-01-02 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2026-01-02 | ||
| Balcom Alexandra | Derivatives Exercise | 34,500 | 2025-12-23 | ||
| Porter James Richard | Derivatives Exercise | 57,000 | 2025-12-23 | ||
| Pelish Henry E. | Derivatives Exercise | 5,085 | 2025-12-23 | ||
| Squarer Ron | Grant, award...etc | 2,837 | 2025-12-11 | ||
| Balcom Alexandra | Sale | -7,084 | $110.31 | $781,436 | 2025-12-10 |
| Noci Darlene | Sale | -4,000 | $107.85 | $431,400 | 2025-12-02 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-12-02 | ||
| Shair Matthew | Sale | -1,650 | $107.7 | $177,705 | 2025-11-26 |
| Shair Matthew | Sale | -5,850 | $107.7 | $630,045 | 2025-11-26 |
| Flynn James E | Sale | -371,287 | $95.44 | $35,437,488 | 2025-11-24 |
| Flynn James E | Sale | -371,287 | $95.44 | $35,437,488 | 2025-11-24 |
| Balcom Alexandra | Sale | -20,729 | $93.8 | $1,944,380 | 2025-11-19 |
| Balcom Alexandra | Derivatives Exercise | 20,729 | 2025-11-19 | ||
| Miller Deborah Ann | Sale | -24,200 | $105.16 | $2,544,872 | 2025-11-19 |
| Miller Deborah Ann | Derivatives Exercise | 24,200 | 2025-11-19 | ||
| Noci Darlene | Sale | -4,000 | $98.91 | $395,640 | 2025-10-31 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-10-31 | ||
| Miller Deborah Ann | Sale | -21,800 | $96.65 | $2,106,970 | 2025-10-31 |
| Miller Deborah Ann | Derivatives Exercise | 21,800 | 2025-10-31 | ||
| Shair Matthew | Sale | -13,200 | $100.23 | $1,323,036 | 2025-10-29 |
| Shair Matthew | Sale | -46,800 | $100.23 | $4,690,764 | 2025-10-29 |
| Miller Deborah Ann | Sale | -5,000 | $94.91 | $474,550 | 2025-10-22 |
| Miller Deborah Ann | Derivatives Exercise | 5,000 | 2025-10-22 | ||
| Pelish Henry E. | Sale | -14,205 | $90.04 | $1,279,018 | 2025-10-17 |
| Pelish Henry E. | Derivatives Exercise | 14,205 | 2025-10-17 | ||
| Porter James Richard | Sale | -27,000 | $90.01 | $2,430,270 | 2025-10-17 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-10-17 | ||
| Balcom Alexandra | Sale | -1,683 | $85.57 | $144,014 | 2025-10-17 |
| Balcom Alexandra | Derivatives Exercise | 1,683 | 2025-10-17 | ||
| Miller Deborah Ann | Sale | -28,000 | $89.98 | $2,519,440 | 2025-10-17 |
| Miller Deborah Ann | Derivatives Exercise | 28,000 | 2025-10-17 | ||
| Balcom Alexandra | Sale | -40,000 | $87.9 | $3,516,000 | 2025-10-15 |
| Balcom Alexandra | Derivatives Exercise | 40,000 | 2025-10-15 | ||
| Pelish Henry E. | Sale | -10,070 | $89.81 | $904,387 | 2025-10-15 |
| Pelish Henry E. | Derivatives Exercise | 10,070 | 2025-10-15 | ||
| Balcom Alexandra | Sale | -20,000 | $85.43 | $1,708,600 | 2025-10-03 |
| Balcom Alexandra | Derivatives Exercise | 20,000 | 2025-10-03 | ||
| Noci Darlene | Sale | -4,000 | $81.39 | $325,560 | 2025-10-01 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-10-01 | ||
| Balcom Alexandra | Sale | -27,588 | $85.01 | $2,345,256 | 2025-10-01 |
| Balcom Alexandra | Derivatives Exercise | 27,588 | 2025-10-01 | ||
| Porter James Richard | Sale | -27,000 | $78.42 | $2,117,340 | 2025-09-17 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-09-17 | ||
| Pelish Henry E. | Sale | -3,725 | $78.83 | $293,642 | 2025-09-12 |
| Pelish Henry E. | Derivatives Exercise | 3,725 | 2025-09-12 | ||
| Pelish Henry E. | Derivatives Exercise | 5,007 | 2025-09-03 | ||
| Noci Darlene | Sale | -4,000 | $73.96 | $295,840 | 2025-08-27 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-08-27 | ||
| Porter James Richard | Sale | -27,000 | $75.22 | $2,030,940 | 2025-08-19 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-08-19 | ||
| Pelish Henry E. | Sale | -5,500 | $74.85 | $411,675 | 2025-08-08 |
| Pelish Henry E. | Derivatives Exercise | 5,500 | 2025-08-08 | ||
| Noci Darlene | Sale | -4,000 | $80.36 | $321,440 | 2025-08-01 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-08-01 | ||
| Porter James Richard | Sale | -27,000 | $81.64 | $2,204,280 | 2025-07-17 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-07-17 | ||
| Balcom Alexandra | Sale | -20,000 | $82.67 | $1,653,400 | 2025-07-17 |
| Balcom Alexandra | Derivatives Exercise | 20,000 | 2025-07-17 | ||
| Pelish Henry E. | Derivatives Exercise | 5,500 | 2025-07-11 | ||
| Pelish Henry E. | Sale | -7,645 | $81.08 | $619,857 | 2025-07-11 |
| Balcom Alexandra | Sale | -20,000 | $80.02 | $1,600,400 | 2025-07-01 |
| Balcom Alexandra | Derivatives Exercise | 20,000 | 2025-07-01 | ||
| Noci Darlene | Sale | -4,000 | $77.38 | $309,520 | 2025-06-27 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-06-27 | ||
| Pelish Henry E. | Sale | -10,800 | $79.87 | $862,596 | 2025-06-27 |
| Pelish Henry E. | Derivatives Exercise | 10,800 | 2025-06-27 | ||
| Shair Matthew | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Protopapas Anna | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Meyers Michael L. | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Pearlberg Joseph | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Bogle Grant C. | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Oliger Christy J. | Grant, award...etc | 3,971 | 2025-06-20 | ||
| Flynn James E | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Flynn James E | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Wheeler Cameron | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Srivastava Sapna | Grant, award...etc | 2,647 | 2025-06-20 | ||
| Porter James Richard | Sale | -27,000 | $76.66 | $2,069,820 | 2025-06-17 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-06-17 | ||
| Pelish Henry E. | Sale | -200 | $79.82 | $15,964 | 2025-06-10 |
| Pelish Henry E. | Derivatives Exercise | 200 | 2025-06-10 | ||
| Noci Darlene | Sale | -4,000 | $71.25 | $285,000 | 2025-05-30 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-05-30 | ||
| Porter James Richard | Sale | -27,000 | $69.28 | $1,870,560 | 2025-05-16 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-05-16 | ||
| Noci Darlene | Sale | -4,000 | $74.56 | $298,240 | 2025-05-01 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-05-01 | ||
| Porter James Richard | Sale | -27,000 | $68.31 | $1,844,370 | 2025-04-17 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-04-17 | ||
| Noci Darlene | Sale | -4,000 | $72.91 | $291,640 | 2025-03-28 |
| Noci Darlene | Derivatives Exercise | 4,000 | 2025-03-28 | ||
| Porter James Richard | Sale | -27,000 | $75.29 | $2,032,830 | 2025-03-19 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-03-19 | ||
| Noci Darlene | Sale | -34,000 | $70.65 | $2,402,100 | 2025-03-10 |
| Noci Darlene | Derivatives Exercise | 34,000 | 2025-03-10 | ||
| Shair Matthew | Sale | -2,000 | $77.51 | $155,020 | 2025-02-25 |
| Porter James Richard | Sale | -27,000 | $78.44 | $2,117,880 | 2025-02-20 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-02-20 | ||
| Pelish Henry E. | Derivatives Exercise | 3,120 | 2025-02-04 | ||
| Shair Matthew | Sale | -2,000 | $82.24 | $164,480 | 2025-01-29 |
| Porter James Richard | Sale | -27,000 | $74.94 | $2,023,380 | 2025-01-17 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2025-01-17 | ||
| Balcom Alexandra | Sale | -4,016 | $78.28 | $314,372 | 2025-01-08 |
| Balcom Alexandra | Grant, award...etc | 18,750 | 2025-01-08 | ||
| Porter James Richard | Sale | -17,301 | $78.28 | $1,354,322 | 2025-01-08 |
| Porter James Richard | Grant, award...etc | 56,250 | 2025-01-08 | ||
| Turner Christopher Durant | Sale | -4,016 | $78.28 | $314,372 | 2025-01-08 |
| Turner Christopher Durant | Grant, award...etc | 18,750 | 2025-01-08 | ||
| Noci Darlene | Sale | -4,016 | $78.28 | $314,372 | 2025-01-08 |
| Noci Darlene | Grant, award...etc | 18,750 | 2025-01-08 | ||
| Pelish Henry E. | Sale | -2,483 | $78.28 | $194,369 | 2025-01-08 |
| Pelish Henry E. | Grant, award...etc | 18,750 | 2025-01-08 | ||
| Miller Deborah Ann | Sale | -2,964 | $78.28 | $232,022 | 2025-01-08 |
| Miller Deborah Ann | Grant, award...etc | 18,750 | 2025-01-08 | ||
| Shair Matthew | Sale | -2,000 | $83.62 | $167,240 | 2024-12-26 |
| Porter James Richard | Derivatives Exercise | 22,000 | 2024-12-20 | ||
| Balcom Alexandra | Derivatives Exercise | 13,700 | 2024-12-18 | ||
| Porter James Richard | Sale | -27,000 | $86.46 | $2,334,420 | 2024-12-18 |
| Porter James Richard | Derivatives Exercise | 27,000 | 2024-12-18 | ||
| Pelish Henry E. | Derivatives Exercise | 10,414 | 2024-12-18 | ||
| Hack Andrew A. F. | Sale | -1,250,000 | $88 | $110,000,000 | 2024-12-13 |
| Bogle Grant C. | Grant, award...etc | 3,200 | 2024-12-09 |
The information provided in this report about NUVL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Nuvalent, Inc.(NASDAQ:NUVL)Â 
Nuvalent, Inc., a preclinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor, designed to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant muta...
Website: http://www.nuvalent.com
Founded: 2017
CEO: James Porter Â
Sector: Healthcare
Industry: Biotechnology